Author

Derek J. Richard

Queensland University of TechnologyORCID 0000-0002-4839-8471Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:statistical model· 1

Frequent Co-Authors

Aayush Kumar TyagiiD· 1 shared David KunkeiD· 1 shared Harsha GowdaiD· 1 shared Mayur Dashrath DivateiD· 1 shared Parastoo ShahrouziiD· 1 shared Pascal H. G. DuijfiD· 1 shared Prathosh A. Prasad· 1 shared Shivashankar Hiriyur NagarajiD· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Aayush Kumar TyagiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyBreast Cancer ResearchPeer-reviewedNov 27, 2024

Loss of chromosome cytoband 13q14.2 orchestrates breast cancer pathogenesis and drug response

Parastoo Shahrouzi, Youness Azimzade, Wioletta Brankiewicz…·Pascal H. G. Duijf

This study identifies the loss of chromosome 13q14.2 as a key driver of breast cancer pathogenesis and drug response, showing its impact on tumor survival, cell cycle, and treatment susceptibility.

5 citations

humanbulk RNA-seq

𝕏 PostBluesky

BioinformaticsCancersPeer-reviewedFeb 24, 2022

Deep learning-based pan-cancer classification model reveals cancer-specific gene expression signatures

Mayur Dashrath Divate, Aayush Kumar Tyagi, Derek J. Richard…·Shivashankar Hiriyur Nagaraj

This study uses deep learning to classify 37 cancer types from TCGA data, identifying cancer-specific gene expression signatures with >97% accuracy.

56 citationstop 5%

humanbulk RNA-seq

𝕏 PostBluesky